The chemokine receptor CXCR2 ligand KC (CXCL1) mediates neutrophil recruitment and is critical for development of experimental lyme arthritis and carditis

Infection and Immunity

Volumn 78, Issue 11, 2010, Pages 4593-4600

  Ritzman, Anna M ^a   Hughes Hanks, Jennifer M ^a   Blaho, Victoria A ^a   Wax, Laura E ^a   Mitchell, William J ^a   Brown, Charles R ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR2; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANKLE; ARTICLE; BORRELIA BURGDORFERI; CARDITIS; CONTROLLED STUDY; DISEASE SEVERITY; EXPERIMENTAL MODEL; FEMALE; INFLAMMATION; INNATE IMMUNITY; KNOCKOUT MOUSE; LYME DISEASE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCORING SYSTEM; SWELLING; WILD TYPE;

ANIMALS; ARTHRITIS, EXPERIMENTAL; BORRELIA BURGDORFERI; CHEMOKINE CXCL1; DISEASE MODELS, ANIMAL; FEMALE; LIGANDS; LYME DISEASE; MALE; MICE; MICE, INBRED C3H; MICE, KNOCKOUT; MYOCARDITIS; NEUTROPHIL INFILTRATION; NEUTROPHILS; RECEPTORS, INTERLEUKIN-8B; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION;

EID: 78049428339     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00798-10     Document Type: Article

References (56)

1. Anguita, J., S. W. Barthold, S. Samanta, J. Ryan, and E. Fikrig. 1999. Selective anti-inflammatory action of interleukin-11 in murine Lyme disease: arthritis decreases while carditis persists. J. Infect. Dis. 179:734-737.
2. Anguita, J., D. H. Persing, M. Rincon, S. W. Barthold, and E. Fikrig. 1996. Effect of anti-interleukin 12 treatment on murine lyme borreliosis. J. Clin. Invest. 97:1028-1034.
3. Armstrong, A. L., S. W. Barthold, D. H. Persing, and D. S. Beck. 1992. Carditis in Lyme disease susceptible and resistant strains of laboratory mice infected with Borrelia burgdorferi. Am. J. Trop. Med. Hyg. 47:249-258.
4. Armstrong, D. A., J. A. Major, A. Chudyk, and T. A. Hamilton. 2004. Neutrophil chemoattractant genes KC and MIP-2 are expressed in different cell populations at sites of surgical injury. J. Leukoc. Biol. 75:641-648.
5. Barsante, M. M., T. M. Cunha, M. Allegretti, F. Cattani, F. Policani, C. Bizzarri, W. L. Tafuri, S. Poole, F. Q. Cunha, R. Bertini, and M. M. Teixeira. 2008. Blockade of the chemokine receptor CXCR2 ameliorates adjuvant-induced arthritis in rats. Br. J. Pharmacol. 153:992-1002.
6. Barthold, S. W., D. S. Beck, G. M. Hansen, G. A. Terwilliger, and K. D. Moody. 1990. Lyme borreliosis in selected strains and ages of laboratory mice. J. Infect. Dis. 162:133-138.
7. Barthold, S. W., K. D. Moody, G. A. Terwilliger, P. H. Duray, R. O. Jacoby, and A. C. Steere. 1988. Experimental Lyme arthritis in rats infected with Borrelia burgdorferi. J. Infect. Dis. 157:842-846.
8. + CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets. Pharmacol. Ther. 112:139-149.
9. Brown, C. R., V. A. Blaho, K. L. Fritsche, and C. M. Loiacono. 2006. Stat1 deficiency exacerbates carditis but not arthritis during experimental Lyme borreliosis. J. Interferon Cytokine Res. 26:390-399.
10. Brown, C. R., V. A. Blaho, and C. M. Loiacono. 2003. Susceptibility to experimental Lyme arthritis correlates with KC and monocyte chemoattractant protein-1 production in joints and requires neutrophil recruitment via CXCR2. J. Immunol. 171:893-901.
11. Brown, C. R., A. Y. C. Lai, S. T. Callen, V. A. Blaho, J. M. Hughes, and W. J. Mitchell. 2008. Adenoviral delivery of interleukin-10 fails to attenuate experimental Lyme disease. Infect. Immun. 76:5500-5507.
12. Brown, C. R., and S. L. Reiner. 1998. Clearance of Borrelia burgdorferi may not be required for resistance to experimental Lyme arthritis. Infect. Immun. 66:2065-2071.
13. Carter, R. A., I. K. Campbell, K. L. O'Donnel, and I. P. Wicks. 2002. Vascular cell adhesion molecule-1 (VCAM-1) blockade in collagen-induced arthritis reduces joint involvement and alters B cell trafficking. Clin. Exp. Immunol. 128:44-51.
14. Cassatella, M. A. 1999. Neutrophil-derived proteins: selling cytokines by the pound. Adv. Immunol. 73:369-509.
15. Coelho, F. M., V. Pinho, F. A. Amaral, D. Sachs, V. V. Costa, D. H. Rodrigues, A. T. Vieira, T. A. Silva, D. G. Souza, R. Bertini, A. L. Teixeira, and M. M. Teixeira. 2008. The chemokine receptors CXCR1/CXCR2 modulate antigen-induced arthritis by regulating adhesion of neutrophils to the synovial microvasculature. Arthritis Rheum. 58:2329-2337.
16. Damsker, J. M., I. Okwumabua, T. Pushkarsky, K. Arora, M. I. Bukrinsky, and S. L. Constant. 2009. Targeting the chemotactic function of CD147 reduces collagen-induced arthritis. Immunology 126:55-62.
17. Endlich, B., D. Armstrong, J. Brodsky, M. Novotny, and T. A. Hamilton. 2002. Distinct temporal patterns of macrophage-inflammatory protein-2 and KC chemokine gene expression in surgical injury. J. Immunol. 168:3586-3594.
18. Eyles, J. L., M. J. Hickey, M. U. Norman, B. A. Croker, A. W. Roberts, S. F. Drake, W. G. James, D. Metcalf, I. K. Campbell, and I. P. Wicks. 2008. A key role for G-CSF-induced neutrophil production and trafficking during inflammatory arthritis. Blood 112:5193-5201.
19. Fujiwara, K., S. Ohkawara, K. Takagi, M. Yoshinaga, and A. Matsukawa. 2002. Involvement of CXC chemokine growth-related oncogene-alpha in monosodium urate crystal-induced arthritis in rabbits. Lab. Invest. 82:1297-1304.
20. Grespan, R., S. Y. Fukada, H. P. Lemos, S. M. Vieira, M. H. Napimoga, M. M. Teixeira, A. R. Fraser, F. Y. Liew, I. B. McInnes, and F. Q. Cunha. 2008. CXCR2-specific chemokines mediate leukotriene B4-dependent recruitment of neutrophils to inflamed joints in mice with antigen-induced arthritis. Arthritis Rheum. 58:2030-2040.
21. -/- mice. Infect. Immun. 73:7637-7643.
22. Halloran, M. M., J. M. Woods, R. M. Strieter, Z. Szekanecz, M. V. Volin, S. Hosaka, G. K. Haines III, S. L. Kunkel, M. D. Burdick, A. Walz, and A. E. Koch. 1999. The role of an epithelial neutrophil-activating peptide-78-like protein in rat adjuvant-induced arthritis. J. Immunol. 162:7492-7500.
23. Issekutz, A. C., J. Y. Mu, G. Liu, J. Melrose, and E. L. Berg. 2001. E-selectin, but not P-selectin, is required for development of adjuvant-induced arthritis in the rat. Arthritis Rheum. 44:1428-1437.
24. Jacobs, J. P., A. Ortiz-Lopez, J. J. Campbell, C. J. Gerard, D. Mathis, and C. Benoist. 2010. Deficiency of CXCR2, but not other chemokine receptors, attenuates autoantibody-mediated arthritis in a murine model. Arthritis Rheum. 62:1921-1932.
25. Jia, N., U. Semba, H. Nishiura, A. Kuniyasu, T. K. Nsiama, N. Nishino, and T. Yamamoto. 2010. Interconversion between pure chemotactic ligands and chemoattractant/secretagogue ligands of neutrophil C5a receptor by a single amino acid substitution. J. Leukoc. Biol. 87:965-975.
26. Kenefick, K. B., J. A. Lederer, R. F. Schell, and C. J. Czuprynski. 1992. Borrelia burgdorferi stimulates release of interleukin-1 activity from bovine peripheral blood monocytes. Infect. Immun. 60:3630-3634.
27. Koch, A. E. 2005. Chemokines and their receptors in rheumatoid arthritis: future targets? Arthritis Rheum. 52:710-721.
28. Koch, A. E., S. L. Kunkel, L. A. Harlow, D. D. Mazarakis, G. K. Haines, M. D. Burdick, R. M. Pope, A. Walz, and R. M. Strieter. 1994. Epithelial neutrophil activating peptide-78: a novel chemotactic cytokine for neutrophils in arthritis. J. Clin. Invest. 94:1012-1018.
29. Koch, A. E., S. L. Kunkel, M. R. Shah, S. Hosaka, M. M. Halloran, G. K. Haines, M. D. Burdick, R. M. Pope, and R. M. Strieter. 1995. Growth-related gene product α. A chemotactic cytokine for neutrophils in rheumatoid arthritis. J. Immunol. 155:3660-3666.
30. Kraan, M., D. Patel, J. Haringman, M. Smith, H. Weedon, M. Ahern, F. Breedveld, and P. Tak. 2001. The development of clinical signs of rheumatoid synovial inflammation is associated with increased synthesis of the chemokine CXCL8 (interleukin-8). Arthritis Res. 3:65-71. (Pubitemid 32223807)
31. Lemos, H. P., R. Grespan, S. M. Vieira, T. M. Cunha, W. A. Verri, K. S. S. Fernandes, F. O. Souto, I. B. McInnes, S. H. Ferreira, F. Y. Liew, and F. Q. Cunha. 2009. Prostaglandin mediates IL-23/IL-17-induced neutrophil migration in inflammation by inhibiting IL-12 and IFNγ production. Proc. Natl. Acad. Sci. U. S. A. 106:5954-5959.
32. Lomas, J. L., C. S. Chung, P. S. Grutkoski, B. W. LeBlanc, L. Lavigne, J. Reichner, S. H. Gregory, L. A. Doughty, W. G. Cioffi, and A. Ayala. 2003. Differential effects of macrophage inflammatory chemokine-2 and keratinocyte-derived chemokine on hemorrhage-induced neutrophil priming for lung inflammation: assessment by adoptive cells transfer in mice. Shock 19:358-365.
33. Lusitani, D., S. E. Malawista, and R. R. Montgomery. 2003. Calprotectin, an abundant cytosolic protein from human polymorphonuclear leukocytes, inhibits the growth of Borrelia burgdorferi. Infect. Immun. 71:4711-4716.
34. Ma, Y., K. P. Seiler, E. J. Eichwald, J. H. Weis, C. Teuscher, and J. J. Weis. 1998. Distinct characteristics of resistance to Borrelia burgdorferi-induced arthritis in C57BL/6N mice. Infect. Immun. 66:161-168.
35. Mackay, C. R. 2008. Moving targets: cell migration inhibitors as new antiinflammatory therapies. Nat. Immunol. 9:988-998.
36. Min, S. H., Y. Wang, W. Gonsiorek, G. Anilkumar, J. Kozlowski, D. Lundell, J. S. Fine, and E. P. Grant. 2010. Pharmacological targeting reveals distinct roles for CXCR2/CXCR1 and CCR2 in a mouse model of arthritis. Biochem. Biophys. Res. Commun. 391:1080-1086.
37. Montgomery, R. R., D. Lusitani, A. B. Chevance Ad, and S. E. Malawista. 2002. Human phagocytic cells in the early innate immune response to Borrelia burgdorferi. J. Infect. Dis. 185:1773-1779.
38. Montgomery, R. R., C. J. Booth, X. Wang, V. A. Blaho, S. E. Malawista, and C. R. Brown. 2007. Recruitment of macrophages and polymorphonuclear leukocytes in Lyme carditis. Infect. Immun. 75:613-620.
39. Morrison, T. B., Y. Ma, J. H. Weis, and J. J. Weis. 1999. Rapid and sensitive quantification of Borrelia burgdorferi-infected mouse tissues by continuous fluorescent monitoring of PCR. J. Clin. Microbiol. 37:987-992.
40. Morrison, T. B., J. H. Weis, and J. J. Weis. 1997. Borrelia burgdorferi outer surface protein A (OspA) activates and primes human neutrophils. J. Immunol. 158:4838-4845.
41. Pahl, A., U. Kuhlbrandt, K. Brune, M. Rollinghoff, and A. Gessner. 1999. Quantitative detection of Borrelia burgdorferi by real-time PCR. J. Clin. Microbiol. 37:1958-1963.
42. Palmer, G., N. Busso, M. Aurrand-Lions, D. Talabot-Ayer, V. Chobaz-Peclat, C. Zimmerli, P. Hammel, B. Imhof, and C. Gabay. 2007. Expression and function of junctional adhesion molecule-C in human and experimental arthritis. Arthritis Res. Ther. 9:1-12.
43. Pillinger, M. H., and S. B. Abramson. 1995. The neutrophil in rheumatoid arthritis. Rheum. Dis. Clin. North Am. 21:691-714.
44. Rovai, L. E., H. R. Herschman, and J. B. Smith. 1998. The murine neutrophil- chemoattractant chemokines LIX, KC, and MIP-2 have distinct induction kinetics, tissue distributions, and tissue-specific sensitivities to glucocorticoid regulation in endotoxemia. J. Leukoc. Biol. 64:494-502.
45. + T cell interactions. J. Infect. Dis. 171:362-370.
46. Santos, L. L., E. F. Morand, P. Hutchinson, N. W. Boyce, and S. R. Holdsworth. 1997. Anti-neutrophil monoclonal antibody therapy inhibits the development of adjuvant arthritis. Clin. Exp. Immunol. 107:248-253.
47. Schrier, D., R. B. Gilbertsen, M. Lesch, and J. Fantone. 1984. The role of neutrophils in type II collagen-induced arthritis in rats. Am. J. Pathol. 117:26-29.
48. Schrier, D. J., R. C. Schimmer, C. M. Flory, D. K. Tung, and P. A. Ward. 1998. Role of chemokines and cytokines in a reactivation model of arthritis in rats induced by injection with streptococcal cell walls. J. Leukoc. Biol. 63:359-363.
49. Soehnlein, O., L. Lindbom, and C. Weber. 2009. Mechanisms underlying neutrophil-mediated monocyte recruitment. Blood 114:4613-4623.
50. Steere, A. C., W. P. Batsford, M. Weinberg, J. Alexander, H. J. Berger, S. Wolfson, and S. E. Malawista. 1980. Lyme carditis: cardiac abnormalities of Lyme disease. Ann. Intern. Med. 93:8-16.
51. Szekanecz, Z., and A. Koch. 2008. Vascular involvement in rheumatic diseases: 'vascular rheumatology.' Arthritis Res. Ther. 10:224-233.
52. Vergunst, C. E., D. M. Gerlag, L. Lopatinskaya, L. Klareskog, M. D. Smith, F. van den Bosch, H. J. Dinant, Y. Lee, T. Wyant, E. W. Jacobson, D. Baeten, and P. P. Tak. 2008. Modulation of CCR2 in rheumatoid arthritis: a doubleblind, randomized, placebo-controlled clinical trial. Arthritis Rheum. 58:1931-1939.
53. Weissmann, G., and H. Korchak. 1984. Rheumatoid arthritis. The role of neutrophil activation. Inflammation 8(Suppl.):S3-S14.
54. Wipke, B. T., and P. M. Allen. 2001. Essential role of neutrophils in the initiation and progression of a murine model of rheumatoid arthritis. J. Immunol. 167:1601-1608.
55. Xu, Q., S. V. Seemanapalli, K. E. Reif, C. R. Brown, and F. T. Liang. 2007. Increasing the recruitment of neutrophils to the site of infection dramatically attenuates Borrelia burgdorferi infectivity. J. Immunol. 178:5109-5115.
56. Zhou, J. S., W. Xing, D. S. Friend, K. F. Austen, and H. R. Katz. 2007. Mast cell deficiency in KitW-sh mice does not impair antibody-mediated arthritis. J. Exp. Med. 204:2797-2802.